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Abstract
Background: The rate-limiting step in prostaglandin (PG) biosynthesis is catalyzed by phospholipase A2 (PLA2) enzymes
which hydrolyze arachidonic acid from membrane phospholipids. Despite their importance in uterine PG production,
little is known concerning the specific PLA2 enzymes that regulate arachidonic acid liberation in the uterine
endometrium. The objectives of this study were to evaluate the expression and activities of calcium-independent Group
VI and Group IVC PLA2 (PLA2G6 and PLA2G4C) and calcium-dependent Group IVA PLA2 (PLA2G4A) enzymes in the
regulation of bovine uterine endometrial epithelial cell PG production.
Methods: Bovine endometrial epithelial cells in culture were treated with oxytocin, interferon-tau and the PLA2G6
inhibitor bromoenol lactone, alone and in combination. Concentrations of PGF2alpha and PGE2 released into the
medium were analyzed. Western blot analysis was performed on cellular protein to determine the effects of treatments
on expression of PLA2G4A, PLA2G6 and PLA2G4C. Group-specific PLA2 activity assays were performed on cell lysates
following treatment with oxytocin, interferon-tau or vehicle (control), alone and in combination. To further evaluate the
role of specific PLA2 enzymes in uterine cell PG biosynthesis, cells were transfected with cDNAs encoding human
PLA2G6 and PLA24C, treated as described above and PG assays performed.
Results:  Constitutive cell production of PGF2alpha was about two-fold higher than PGE2. Oxytocin stimulated
production of both PGs but the increase of PGF2alpha was significantly greater. Interferon-tau diminished oxytocin
stimulation of both PGs. The PLA2G6 inhibitor, bromoenol lactone, abolished oxytocin-stimulated production of
PGF2alpha. Treatments had little effect on PLA2G4A protein expression. In contrast, oxytocin enhanced expression of
PLA2G6 and this effect was diminished in the presence of interferon-tau. Expression of PLA2G4C was barely detectable
in control and oxytocin treated cells but it was enhanced in cells treated with interferon-tau. Oxytocin stimulated PLA2
activity in assays designed to evaluate PLA2G6 activity and interferon-tau inhibited this response. In assays designed to
measure PLA2G4C activity, only interferon-tau was stimulatory. Cells overexpressing PLA2G6 produced similar
quantities of the two PGs and these values were significantly higher than PG production by non-transfected cells.
Oxytocin stimulated production of both PGs and this response was inhibited by interferon-tau. Bromoenol lactone
inhibited oxtocin stimulation of PGF2alpha production but stimulated PGE2 production, both in the absence and
presence of oxytocin. Cells over-expressing PLA2G4C produced more PGE2 than PGF2alpha and interferon-tau
stimulated PGE2 production.
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Conclusion: Results from these studies indicate that oxytocin stimulation of uterine PGF2alpha production is mediated,
at least in part, by up-regulation of PLA2G6 expression and activity. In addition to its known inhibitory effect on oxytocin
receptor expression, interferon-tau represses oxytocin-stimulated PLA2G6 expression and activity and this contributes
to diminished PGF2alpha production. Furthermore, endometrial cell PGE2 biosynthesis was associated with PLA2G4C
expression and activity and interferon-tau was stimulatory to this process.
Background
In domestic ruminants (sheep, cattle, goats) estrous
cyclicity is regulated by uterine PGF2α-induced demise of
the corpus luteum [1,2]. PGF2α is released from endome-
trial luminal and superficial glandular epithelium in an
episodic fashion toward the end of the estrous cycle. Oxy-
tocin (OT), of neurohypophyseal and luteal origin, is
believed to bind endometrial OT receptors and initiate
pulsatile PGF2α secretion, which in turn, stimulates release
of luteal OT and creates a positive feedback loop that
results in several series of pulses of short duration which
are effective in causing luteolysis [3,4]. During early preg-
nancy, the conceptus protein interferon tau (IFNT) binds
to endometrial receptors and attenuates episodic PGF2α
secretion, thereby rescuing the CL from regression and
maintaining progesterone production [5-7].
Release of arachidonic acid (AA) from membrane glycero-
phospholipids is catalyzed by phospholipase A2 enzymes
and is considered the rate-limiting step in PG biosynthesis
[8]. Released AA is then metabolized to PGG2  by a
cyclooxygenase reaction and then to PGH2 by a peroxi-
dase reaction, both mediated by cyclooxygenase (COX) -
1 and/or -2. Terminal PG synthases, which exhibit tissue-
specific distribution, then convert PGH2 to bioactive PGs
including PGF2α, PGE2, PGD2 and PGI2.
Although PLA2 activation catalyzes the rate-limiting step
in PG biosynthesis, most investigations of the mecha-
nisms and regulation of uterine PG production have
focused on the activation and expression of down-stream
enzymes, such as the cyclooxygenases and PG synthases.
The few studies [9-12] that have examined the role of
PLA2 in uterine PG production in domestic ruminants
have focused on a single enzyme, cPLA2α (Group IVA
PLA2 or PLA2G4A). Surprisingly, none of these studies
identified consistent changes in expression of protein or
mRNA for PLA2G4A in association with alterations in PG
production. In contrast, non-specific PLA2 inhibitors sig-
nificantly diminished both basal and agonist-induced PG
production [10-12].
Mammalian cells contain structurally diverse PLA2
enzymes that differ in their location and regulation
[reviewed in [13] and [14]]. At least 14 groups, and
numerous subgroups, of PLA2s have been classified.
These groups include four main families of PLA2s, the low
molecular weight secretory PLA2s, the cytosolic PLA2G4s,
the calcium-independent PLA2G6s and the platelet acti-
vating factor (PAF) acid hydrolases (PLA2G7 and
PLA2G8). The intracellular PLA2G4 and PLA2G6
enzymes are specifically important in the regulation of PG
biosynthesis because their sites of action are the perinu-
clear membranes where down-stream AA metabolizing
enzymes (cyclooxygenases and PG synthases) reside.
The first cytosolic PLA2 discovered was PLA2G4A and it
has received, by far, the most attention. It is a 749 amino
acid, 85 kDa protein that migrates at 100–112 kDa in
polyacrylamide gels. It is present in the cytosol of resting
cells and upon activation by a variety of agonists, under-
goes Ca++-directed translocation to perinuclear mem-
branes. The N-terminal Ca++-dependent lipid binding
(CaLB) or C2 domain is essential for membrane associa-
tion and responsible for translocation in response to stim-
uli that increase intracellular calcium [14+]. Gene
disruption studies have indicated an important role for
PLA2G4A in normal fertility, eicosanoid production from
inflammatory cells, brain injury and allergic response in
mice [15-17]. Mice with a null mutation for the gene have
fewer implantation sites, smaller litters and fail to
undergo labor at term.
Several additional Group IV PLA2 enzymes have been
cloned recently, including IVB, IVC, IVD, IVE and IVF [18-
20]. Of these enzymes, IVC (PLA2γ) is of interest because
it is constitutively associated with membranes, the major
site of prostaglandin biosynthesis, lacks the C2 domain
and does not require Ca++ for activation. Although first
associated with membrane remodeling, recent studies
demonstrate that PLA2G4C functions as a signaling PLA2
linked to PGE2 production [21].
In the literature, the term calcium-independent PLA2, has
generally referred to the Group 6 family of PLA2 enzymes
[13], despite the fact that Group 4C is Ca++-independent
as well. Two distinct subclasses of Group 6 have been
identified and characterized, 6A (also referred to as iPLA2
and iPLA2B) and 6B (iPLA2γ). More recently several novel
iPLA2s have been identified, including iPLA2δ, iPLA2ε,
iPLA2ζ and iPLA2η[22]. These novel iPLA2 family mem-
bers display primarily lysophospholipase, triacylglycerol
lipase and/or transacylase activities rather than PLA2
activity. Group 6A has been cloned and characterized inReproductive Biology and Endocrinology 2007, 5:16 http://www.rbej.com/content/5/1/16
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several species and cell types [23-25]. It has a mass of 85–
88 kDa, contains 7–8 terminal ankyrin repeats, and a con-
sensus lipase motif. Several splice variants of the enzyme
are expressed yielding multiple molecular weight iso-
forms [25]. Recently, expression of a 50 kDa Group 6
enzyme in rat myometrium was associated with agonist-
induced uterine contractions [26].
All PLA2 enzymes catalyze the hydrolysis of the sn-2 ester
bond of phospholipids to produce free fatty acids and lso-
phospholipid [13,14]. A distinguishing characteristic of
PLA2G4A is that it exhibits greater selectivity for lipids
containing arachidonic acid than other cytosolic PLA2s.
For this reason, PLA2G4A has been the enzyme primarily
associated with direct generation of arachidonic acid and
initiation of the eicosanoid cascade. However, PLA2G4C
[21] and PLA2G6 [32,33] have been associated with ago-
nist-stimulated arachidonic acid release and eicosanoid
biosynthesis. In addition, it has been shown that PLA2G6
may mediate release of arachidonic acid directly by
hydrolysis of arachidonate-containing plasmalogens or
through an indirect, multi-step process involving hydrol-
ysis of diacyl lipids to arachidonyl lysophosphatidylcho-
line [34].
The objectives of the present study were to investigate the
expression and activities of Group 4A, 4C and 6A PLA2
enzymes in association with PGF2α and PGE2 production
in bovine endometrial epithelial cell cultures. Results
indicate that in addition to PLA2G4A, PLA2G6 and
PLA2G4C contribute to regulation of uterine cell PG pro-
duction and these latter two enzymes are activated in
response to oxytocin and INFT, respectively.
Methods
Materials
Bovine endometrial epithelial (BEE) cells were from Cell
Applications, Inc. (Catalog no. B932-05, San Diego, CA).
Dulbecco minimum essential medium (MEM), Ham F-
12, Hank's buffered saline solution (HBSS), gentamicin,
oxytocin, PDBu, bovine serum albumin, fetal bovine
serum, horse serum, aprotinin, leupeptin and pepstatin
were from Sigma Chemical Co (St Louis, MO). Enzyme
Immunoassay kits for PGE2 (catalog no. 900-001) and
PGF2α (catalog no. 901-069) were from Assay Designs, Inc
(Ann Arbor, MI). 1-palmitoyl-2-(1-14C) arachidonyl-
phosphotidylcholine (14C-AA-PC), 1-palmitoyl-2-(1-14C)
oleoyl-phosphotidylcholine (14C-OA-PC) and 1-palmi-
toyl-2-(1-14C) linoleoyl-phosphotidylcholine (1-14C-LA)
were from Amersham Corp (Arlington Heights, IL).
Group 4A PLA2 antibody (SC-454) was from Santa Cruz
Biotechnology, Inc (Santa Cruz, CA), Group 6 PLA2 anti-
body (Anti-iPLA2, #07-169) was from Upstate Cell Signal-
ing Solutions (Lake Placid, NY) and the anti-Group 4C
was a gift from Dr. C.C. Leslie (University of Colorado,
Boulder, CO). Recombinant ovine IFNτ (antiviral activity,
1 × 108 U/mg) was donated kindly by Dr. F.W. Bazer
(Texas A&M University, College Station, TX). The PLA2G6
inhibitor, bromoenol lactone (BEL) and the PLA2G4 and
PLA2G6 inhibitor methyl arachidonyl fluorophospho-
nate (MAFP) were from Cayman Chemical (Ann Arbor,
MI) and the PLA2G4A inhibitor, pyrrolidine-1 (PYR-1),
was a gift from Dr. Michael Gelb (University of Washing-
ton, Seattle WA). Tissue culture plasticwares were from
Benton Dickinson and Co. (Franklin Lakes, NJ). Unless
noted otherwise, additional chemicals were from Sigma
Chemical Corp.
Cell culture
Bovine endometrial epithelial cells were cultured and
propagated by procedures suggested by Cell Applications,
Inc. According to the distributor, the cells, isolated from
epithelium of bovine endometrium and cryopreserved at
second passage, can be cultured and propagated for at
least 10 doublings. Briefly, cells were seeded in tissue cul-
ture dishes of the appropriate size for each experiment
(see below) at a concentration of 0.5 × 105 cells per ml in
culture medium (40% Hams F-12, 40% MEM, 200 U
insulin/L, 50 μg/ml gentamicin, 10% FBS and 10% horse
serum) at 37°C in a humidified atmosphere of 95% air
and 5% CO2 and culture medium was changed every
other day.
PG assays
Cells were grown to ~90% confluence in 6-well plates,
washed three times with HBSS and cultured for 6 h in
unsupplemented Hams F-12/MEM with the following
treatments: control, oxytocin (OT, 0.1 μM), IFNT (50 ng/
ml), the PLA2G6 inhibitor BEL (7.5 μM), IFNT + OT and
BEL + OT. Vehicles, Hams F-12/MEM for OT and IFNT,
and DMSO for the inhibitor were added to each well.
Treatments were performed in triplicate and the experi-
ment was repeated (n = 6). At the end of the incubation
period, medium was harvested and stored frozen at -
20°C. Prostaglandin F2α and E2 assays were performed
with enzyme immunoassay kits from Assay Designs, Inc.,
according to supplier's instructions. Inter- and intraassay
coefficients of variation (n = 12) were 9% and 11%,
respectively.
Western blot analysis
Western blot analysis was performed as described previ-
ously (27). Briefly, cells grown to confluence in 60 mm
dishes were treated with vehicle (control), OT and IFNT
(50 ng and 1000 ng), alone and in combination for 6 h as
described above. Treatments were performed in triplicate.
Cells were lysed in RIPA buffer (50 mM Tris-HCl, 150 mM
NaCl, 1% SDS, 0.5% sodium deoxycholate, 1 mM DTT,
100  μM PMSF, 1% NP-40, and 1 × protease inhibitor
cocktail (Roche Applied Science, Indianapolis, IN), soni-Reproductive Biology and Endocrinology 2007, 5:16 http://www.rbej.com/content/5/1/16
Page 4 of 12
(page number not for citation purposes)
cated and centrifuged (10,000 g, 20 minutes). Superna-
tants from each treatment were combined and 30 μg
protein from each treatment was subjected to 10% SDS-
polyacrylamide gel electrophoresis and transferred onto
nitrocellulose membranes. Non-specific binding sites
were blocked with 5% non-fat dry milk and membranes
were incubated with antibodies to PLA2G4A, PLA2G4C,
and PLA2G6 in 1:800, 1:400 and 1:1000 dilutions, respec-
tively, overnight at 4°C. Membranes were rinsed 3 times
and protein bands were visualized using an enhanced flu-
orescent reagent (ECL Western blotting detection kit,
Amersham Biosciences, Piscataway, NJ).
Over expression of PLA2G4C and PLA2G6A in BEE cells
Full-length cDNAs encoding human PLA2G4C (accession
number XM_009119) and PLA2G6A (accession number
XM_039248) were generated via PCR using templates
from human coronary artery endothelial cells. Primers for
PLA2G4C were: upstream 5'CCG CAG TGC ACC ATG
GGA AGC TC 3', downstream 5'C TCC CAG CTA CCC
GGC CAC GTT C 3'. Primers for PLA2G6A were: upstream
5' G GCG GGC ACC GCC ACT GGA GC 3', downstream
5'GAA TGC CCC ATG CGT CTC CCA G 3'. The cDNAs
were ligated into the PCR2.1-TOPO plasmid vector of the
TA cloning system (Invitrogen Corp, Carlsbad, CA), sub-
cloned and sequenced. Homologies with the human
PLA2G4C and PLA2G6A were >99%. The cDNAs were
ligated into the PCR3.1 expression vector (Invitrogen
Corp, Carlsbad, CA). Plasmids were incorporated into
BEE cells using the Superfect™ (Qiagen Inc, Valencia, CA)
transfection system according to manufacturers' instruc-
tions. Over expression of PLA2G4C and PLA2G6 was con-
firmed by Western blot analysis. Cells transfected with
PLA2G6 were treated for 6 h with vehicle (control), IFNT
(50 ng/ml), OT (0.1 μM), OT and IFNT, BEL (7.5 μM),
and BEL and OT. Cells transfected with PLA2G4C were
treated for 6 h with vehicle (control), IFNT (50 ng/ml),
OT (0.1 μM), OT and IFNT. Treatments were performed in
triplicate and repeated (n = 6). Prostaglandin E2 and F2α
assays were performed as described above.
PLA2 activity in cellular homogenates
PLA2  assays were performed on cellular lysates, as
described previously [27], following treatment of intact
cells. Briefly, cells were grown to 80% confluence. Treat-
ments, OT, IFNT, alone and in combination, were applied
for 3 h. Some treatments included the inhibitors, BEL,
MAFP and PYR-1, which were applied 30 min before other
treatments. Concentrations of treatments were as listed
above unless otherwise noted. Experiments were per-
formed in triplicate and repeated twice. At the end of the
incubation period, cells were washed with Ca++-free PBS
containing 5 mM EGTA and 1 mM phenylmethyl-sulfo-
nylchloride (PMSF), lysed in homogenizing buffer (50
mM Tris HCl, pH 7.4, 0.5 mM dithiothreitol, 20% glyc-
erol, 1 μg/ml leupeptin, 10 μg/ml aprotinin, 1 mM PMSF
and sonicated two times for 10 seconds on ice. The sub-
strates 1-palmitoyl-2-[arachidonoyl] phophatidylcholine
(cold AA-PC) and 1-palmitoyl-2-[arachidonoyl-1-14C]
phosphatidylcholine (14C-AA-PC), 1-palmitoyl-2-[linole-
oyl] phosphatidylcholine (cold LA-PC), 1-palmitoyl-2-
[linoleoyl-1-14C] phosphatidlycholine (14C-LA-PC), 1-
palmitoyl-2-[oleoyl] phosphatidylcholine (OA-PC) and
1-palmitoyl-2-[oleoyl-1-14C] phosphatidylcholine (14C-
OA-PC) were used to assay for PLA2 activity. The sub-
strates were dried under nitrogen and resuspended by son-
ication in assay buffer (10 mM Hepes, pH 7.5) to a final
optimum concentration of cold to radiolabeled substrate
as determined previously. In preliminary studies, calcium-
dependent and – independent activities were identified.
Calcium-dependent activity (primarily PLA2G4A) assays
were performed with AA-PC and 14C-AA-PC in the pres-
ence of 5 mM CaCl2 and calcium-independent activity
(primarily PLA2G6 and PLA2G4C) assays were performed
using the same substrates but in the absence of CaCl2 and
the presence of EGTA (5 mM). Assays optimized for iden-
tification of PLA2G4C utilized OA-PC and 14C-OA-PC in
the absence of calcium (this enzyme is arachidonoyl-non-
selective and Ca++-independent) and assays optimized for
PLA2G6 utilized LA-PC and 14C-LA-PC in the absence of
Ca++ and presence of 400 μM Triton-X and 0.8 mM ATP
which enhance the activity of this enzyme [28]. Experi-
ments were terminated by addition of chloroform-metha-
nol, 2:1 (v/v), the chloroform layer was extracted and
lipids separated by thin-layer chromatography (hexane:
diethyl ether: glacial acetic acid, 7:3:0.2). Lipids were vis-
ualized with I2 vapor, the zones corresponding to fatty
acid and phospholipids were excised and radioactivity
determined by scintillation counting.
Statistical analysis
Data for PG production and PLA2 activity are presented as
means +/- SEM and subjected to least squares analysis of
variance using the general linear models procedure of the
Statistical Analysis System (SAS Institute, Cary, NC).
Sources of variance included experiments, treatments and
their interactions. Individual comparisons of means were
made using Student-Neuman-Keuls test in which the
independent variables were the treatments and the
dependent variables were the levels of PG or PLA2 activity
produced. Differences were considered statistically signif-
icant when P < 0.05.
Results
Prostaglandin production
The effects of treatment on PGF2α and PGE2 production by
bovine endometrial epithelial cells are illustrated in Fig-
ure 1. In the absence of stimulation (control), cells pro-
duced about twice the amount of PGF2α as PGE2 (p <
0.05). Oxytocin stimulated PGF2α and PGE2 productionReproductive Biology and Endocrinology 2007, 5:16 http://www.rbej.com/content/5/1/16
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about five fold and two fold, respectively. Alone, IFNT had
little effect on the production of either PG but it signifi-
cantly inhibited the stimulatory effect of oxytocin on
PGF2α production and numerically diminished PGE2 pro-
duction. Alone, BEL, the PLA2G6 inhibitor [30], had little
effect on PGF2α production but enhanced PGE2 synthesis.
In combination with oxytocin, BEL completely abolished
the stimulatory effect of oxytocin on PGF2α but not PGE2
production.
Prostaglandin production by BEE cells transfected with
PLA2G6 plasmids, is illustrated in Figure 2. Overexpres-
sion (OE) of PLA2G6 in BEE cells significantly increased
constitutive production of PGF2α and PGE2 compared to
non-transfected cells (compare values in Fig. 2 to Fig. 1).
Oxytocin significantly increased production of both PGs
by about 50% compared to non-stimulated OE (control)
cells. Alone, IFNT had little effect on PG production but it
diminished, significantly, the stimulatory effect of oxy-
tocin when the treatments were combined. The PLA2G6
inhibitor BEL, alone, did not affect PGF2α production
compared to controls, but it abolished oxytocin stimula-
tion of PGF2α production when the two treatments were
combined. Conversely, BEL dramatically enhanced PGE2
production, alone and in combination with oxytocin.
Figure 3 illustrates results of prostaglandin production by
BEE cells overexpressing the PLA2G4C enzyme. Produc-
tion of both PGs was significantly enhanced compared to
non-transfected cells and the increase in PGE2 was signifi-
cantly greater than that of PGF2α. Alone, IFNT had little
effect on PGF2α production but significantly stimulated
PGE2  production. Oxytocin stimulated production of
both PGs compared to control PLA2G4C transfected cells
and the effect on PGE2 production was greater. When
combined, IFNT diminished oxytocin stimulation of
PGF2α but PGE2 production values were similar to oxy-
tocin and IFNT treatments, alone.
PLA2 protein expression
Western blot analysis of cellular proteins from BEE cells
demonstrated that the PLA2G4A antibody recognized a
protein which migrated at ~110 kD, the PLA2G6 antibody
recognized protein which migrated at 85 kD and the
PLA2G4C antibody cross-reacted with a protein migrating
at 61 kD (Figure 4). Two isoforms of PLA2G6 were iden-
tified, a major band at 85 kd, and a minor band of slightly
greater mass. Similar result have been observed previously
and likely the result of alternative splicing of the PLA2G6
transcript resulting in multiple isoforms of the enzyme
[25]. Cells were treated for 6 h with vehicle (control, lane
1), IFNT (50 ng, lane 2), IFNT(1000 ng, lane 3), oxy-
Prostaglandin F2α and E2 production by BEE cells Figure 1
Prostaglandin F2α and E2 production by BEE cells. Cell culture medium was harvested 6 h after addition of treatments 
and concentrations of PGs were analyzed by ELISA. Treatments included, Control, C; IFNT, I; Oxytocin, O; Oxytocin and 
IFNT, O&I, Bromoenol lactone, B; and Oxytocin and Bromoenol lactone, O&B. Treatments were performed in triplicate and 
repeated (n = 6). Data are expressed as means and SEM. Columns with different superscripts are significantly different (p < 
0.05).
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tocin(0.1 μM, lane 4), oxytocin (0.1 μM) plus 50 ng IFNT
(lane 5) and oxytocin (0.1 μM) plus 1000 ng IFNT (lane
6) to determine the effects of these treatments on PLA2 iso-
type expression. As shown in Figure 4A, expression of
PLA2G6 (Fig 4A) was influenced by treatments. Oxytocin
up-regulated PLA2G6 (Fig 4A, lane 4) and this effect was
diminished by IFNT treatments (Fig 4A, lanes 5 and 6).
Expression of PLA2G4C (Fig 4B) was barely detectable,
except when cells were treated with IFNT, which enhanced
expression of the enzyme (Fig 4B, lanes 2, 3, 5 and 6). In
contrast, PLA2G4A was expressed at similar levels in all
treatment groups (Figure 4C).
PLA2 activity assays
Cell lysate PLA2 assays were performed in an attempt to
identify enzyme-specific activities based on differences in
substrate selectivity, Ca++ requirements, cofactor-depend-
ent activity amplification and specific inhibitor effects.
Figure 5 illustrates that BEE cells exhibit both Ca++-
dependent activity (primarily PLA2G4A) and Ca++-inde-
pendent activity (primarily PLA2G6 and PLA2G4C). Cal-
cium-dependent activity was inhibited by PYR-1, a
PLA2G4A-specific inhibitor [31], MAFP, a G4 and G6
inhibitor [30] and BEL (a PLA2G6-specific inhibitor) due
to the fact that both G4C and G6 PLA2 enzymes do not
require Ca++ for activity but function in its presence. Cal-
cium-independent activity was inhibited by BEL and
MAFP, but not PYR-1, which inhibits only the Ca++-
dependent PLA2G4A.
Figure 6 depicts the results of PLA2 assays designed specif-
ically to evaluate PLA2G6 activity in homogenates of BEE
cells following treated of intact cells for 3 h with or with-
out oxytocin in the presence and absence of IFNT, BEL or
PYR-1. Oxytocin significantly stimulated PLA2G6 activity
and IFNT inhibited this response. Inhibition of oxytocin
Prostaglandin F2α and E2 production by BEE cells over-expressing PLA2G6 Figure 2
Prostaglandin F2α and E2 production by BEE cells over-expressing PLA2G6. Culture medium from BEE cells, trans-
fected with PLA2G6 cDNA, was harvested 6 h after exposure to treatments and concentrations of PGs were analyzed by 
ELISA. Treatments included Control, C; IFNT, I; Oxytocin, O; :Oxytocin and IFNT, O&I, Bromoenol lactone, B; Oxytocin and 
Bromoenol lactone, B&O. Treatments were performed in triplicate and repeated (n = 6). Data are expressed as means and 
SEM. Columns with different superscripts are significantly different (p < 0.05). Western blot at top of figure compares PLA2G6 
expression in transfected cells (lane 1) and non-transfected cells (lane 2).
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stimulation of activity by BEL but not PYR-1 confirms that
PLA2G6 activity was measured.
Results from PLA2 assays designed to measure PLA2G4C
activity are illustrated in Figure 7. BEE cells were treated
for 3 h with vehicle (control), oxytocin, BEL, PYR-1, MAFP
or IFNT. Considerable constitutive activity was present
and this activity was inhibited by the G4 and G6 PLA2
inhibitor MAFP but not the G6-specific inhibitor BEL or
the G4A-specific inhibitor PYR-1. Group IVC PLA2 activity
was significantly stimulated by IFNT.
Discussion
Prostaglandins are essential regulators of numerous repro-
ductive processes but, despite their primary involvement
in fertility regulation, the cellular and molecular mecha-
nisms that regulate prostaglandin production are poorly
understood. The rate-limiting step in prostanoid biosyn-
thesis is at the level of PLA2 enzymes but, surprisingly, lit-
tle is known concerning the regulatory function of specific
PLA2 isoforms that mediate arachidonic acid release and
are likely coupled to downstream enzymes that synthesize
the different PGs in reproductive tissues. Although in vivo
studies may provide the most complete physiological con-
ditions in which to evaluate uterine biology, they are not
best suited for analysis of some cellular mechanisms
involving biochemical pathways. For this reason, we
turned to in vitro cell cultures to evaluate PLA2 regulation
of PG biosynthesis. To our knowledge, this is the first
study to demonstrate that expression and activity of the
calcium-independent PLA2G6 and PLA2G4C in endome-
trial epithelial cells are differentially regulated by oxytocin
and IFNT, resulting in altered prostaglandin biosynthesis.
Three lines of evidence support the concept that PLA2G6
is involved in oxytocin stimulation of endometrial PGF2α
production. One, the PLA2G6 inhibitor BEL abolished
oxytocin stimulation of PGF2α production. Two, oxytocin
increased expression of PLA2G6 as determined by West-
ern blot analysis; and three, PLA2G6-specific activity was
increased by oxytocin and this response was blocked by
BEL. Similarly, the results indicate that IFNT diminished
oxytocin stimulated PLA2G6 expression (Figure 4A, West-
ern blot analysis) and activity (Figure 6) resulting in
diminished PGF2α production (Figure 1). These results do
not exclude PLA2G4A from playing a role in oxytocin-
Prostaglandin F2α and E2 production by BEE cells over-expressing PLA2G4C Figure 3
Prostaglandin F2α and E2 production by BEE cells over-expressing PLA2G4C. Culture medium from BEE cells, trans-
fected with PLA2G4C cDNA, was harvested 6 h after exposure to treatments and concentrations of PGs were analyzed by 
ELISA. Treatments included Control, C; IFNT, I; Oxytocin, O, Oxytocin and IFNT, O&I. Data are expressed as means and 
SEM. Treatments were performed in triplicate and repeated (n = 6). Columns with different superscripts are significantly differ-
ent (p < 0.05). Western blot at top of figure compares PLA2G4C expression in transfected cells (lane 1) and non-transfected 
cells (lane 2).
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stimulated uterine PG production. Indeed, PLA2G4A
knock-out mice fail to initiate labor at term. On the other
hand, the results presented may help to explain why pre-
vious studies [10-12] failed to identify consistent changes
in PLA2G4A expression or activity in response to oxy-
tocin.
The observation that BEL inhibition of PLA2G6 activity
blocked oxytocin stimulation of PGF2α production led to
studies that examined the effects of PLA2G6 overexpres-
sion on PG production. Cells that over expressed this
enzyme produced significantly more PGF2α  and PGE2
than control non-transfected cells. Oxytocin increased
production of both PGs and IFNT diminished these
responses. As expected, BEL inhibited oxytocin-stimulated
PGF2α production. In contrast, BEL, alone or in combina-
tion with oxytocin, greatly enhanced PGE2 production.
Increased PGE2 production in response to BEL was also
observed in non-transfected BEE cells and, in previous
studies [29], we have repeatedly observed stimulation of
PGE2 production by BEL in primary cultures of ovine
endometrial epithelial cells. Although BEL is a relatively
selective PLA2 inhibitor at the concentration used, it has
also been shown to inhibit Mg++-dependent phosphatidic
acid phosphohydrolase (PAP-1), an enzyme that catalyzes
the dephosphorylation of phosphatidic acid to diacylglyc-
erol [30]. Change in PAP-1 activity would not explain the
observed increase in PGE2. Alteration of the PGE2 : PGF2α
ratios could be affected at the level of the PG synthases. To
our knowledge, there is no evidence that BEL affects PGE
synthase expression or activity. In addition, studies in
human monocytes [32] and rat mesangial cells [33] have
demonstrated that stimulation of the arachadonic acid/
PGE cascade is mediated by PLA2G6 activation and BEL
inhibited agonist-stimulated PGE2 production in these
cells. These data would argue against a stimulatory activity
of BEL on PGE2 synthase.
Functional coupling between different PLA2 isoforms,
COX-2 and specific PG synthases has been suggested as a
regulatory mechanism of prostanoid biosynthesis in a
variety of cell types [36-38]. Individual isoforms, coupled
to specific signaling stimuli, may act on different cellular
pools of arachidonic acid at different locations in mem-
branes. Inhibition of PLA2G6 with BEL blocked oxytocin
stimulated PGF2α production but stimulated PGE2 pro-
duction. One possible explanation for the differential
effects of BEL on PG production may be that PLA2G6 is
functionally coupled to PGF2α production which is stimu-
lated by oxytocin and inhibition of PLA2G6 blocks this
response. Conversely, inhibition of PLA2G6 may be per-
missive to activation of other PLA2 isoforms, such as
PLA2G4C, which may be functionally coupled to PGE2
production. Clearly, confirmation of this hypothesis will
require additional studies.
During early pregnancy in ruminants, IFNT not only sup-
presses episodic release of PGF2α from the endometrium,
but it also enhances production of PGE2 [39-41]. PGE2 has
been proposed to have multiple roles in the maintenance
of early pregnancy, including action as a luteotrophic or
luteoprotective signal and as a mediator of endometrial
receptivity [38,39]. The mechanism by which IFNT up-
regulates PGE2 production is unknown but Arosh et al.
Oxytocin and interferon-tau differentially regulate expression of PLA2 enzymes Figure 4
Oxytocin and interferon-tau differentially regulate expression of PLA2 enzymes. BEE cells were treated for 6 h 
with vehicle (control, lane 1), 50 ng IFNT (lane 2), 1000 ng IFNT (lane 3), oxytocin (lane 4), oxytocin plus 50 ng IFNT (lane 5), 
and oxytocin plus 1000 ng IFNT (lane 6). Western blot analyses were performed on cellular proteins using antibodies against 
A, PLA2G6; B, PLA2G4C and C, PLA2G4A as described in the Methods.
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BEE cells exhibit both Ca++-dependent and Ca++-independent PLA2 activities Figure 5
BEE cells exhibit both Ca++-dependent and Ca++-independent PLA2 activities. PLA2 activity assays were performed 
on cellular lysates following treatment of intact cells, as described in the Methods. Ca++-dependent PLA2 activity assays were 
performed with AA-PC and 14C-AA-PC in the presence of 5 mM CaCl2and Ca++-independent assays were performed using the 
same substrates but in the absence of CaCL2 and the presence of 5 mM EGTA. Treatments included the PLA2G6 inhibitor BEL, 
the PLA2G4 and PLA2G6 inhibitor MAFP and the PLA2G4A inhibitor PYR-1. Data from columns with different superscripts 
are significantly different (p < 0.05).
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Oxytocin stimulated PLA2G6 activity is blocked by IFNT Figure 6
Oxytocin stimulated PLA2G6 activity is blocked by IFNT. BEE cells were treated for 3 h with vehicle control, oxy-
tocin, IFNT, BEL or PYR-1, alone or in combination. The symbols, + and -, indicate the presence or absence of treatments, 
respectively. PLA2G6 activity assays were performed on cellular lysates as described in the Methods. Inhibition of activity by 
BEL but not PYR-1 demonstrates that PLA2G6 activity was measured. Columns with different superscripts are significantly dif-
ferent (p < 0.05).
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[39] have shown that it does not enhance PGE2 synthase
expression in bovine endometrium. We propose IFNT reg-
ulation of PGE2 production involves, at least in part, mod-
ulation of expression and activity of a PLA2 isoform.
Results from cell-free PLA2 assays and Western blot analy-
sis demonstrated that PLA2G4C activity and expression
were up-regulated by IFNT. Over expression of PLA2G4C
in BEE cells increased production of both PGs but the
increased PGE2  was significantly greater than the
increased PGF2α. Treatment of these cells with IFNT signif-
icantly stimulated PGE2  production. Together, these
results indicate that the PLA2G4C enzyme is coupled to
PGE2 production and this activity is positively regulated
by IFNT.
Luteolysis, resulting from episodic secretion of PGF2α, is
acknowledged, generally, to be orchestrated progesterone,
estradiol and oxytocin acting through their respective
endometrial receptors [1,2]. During early pregnancy, IFNT
diminishes expression of the estrogen receptor- alpha and
the oxytocin receptor thereby blocking the OT-PGF2α feed-
back loop and preventing luteolysis [41,42]. There can be
little doubt that diminished oxytocin receptor expression
contributes to early pregnancy maintenance in ruminants,
but some studies have indicated that IFNt-mediated
repression of oxytocin receptors is not absolute. For exam-
ple, Burgess et al. [43] demonstrated that PGFM release,
following bolus inter-arterial oxytocin injection, was sim-
ilar in day 14–16 cyclic and pregnant ewes, indicating that
some oxytocin receptor activity remains during early preg-
nancy; and Mann et al. [44] demonstrated in cattle that
oxytocin receptor concentrations were not a limiting fac-
tor in oxytocin stimulated PGFM release. Based on the
results from the present study, it is suggested that in addi-
tion to repressing oxytocin receptor expression, IFNT
diminishes oxytocin stimulation of PLA2G6-linked PGF2α
production and enhances PLA2G4C-linked PGE2 produc-
tion.
Conclusion
Together, the data indicate that uterine PG production is
regulated, at least in part, by the expression and activity of
PLA2 enzymes and that specific PLA2 isotypes may regu-
late the production of specific PGs.
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PLA2G4C activity is enhanced by IFNT but not oxytocin Figure 7
PLA2G4C activity is enhanced by IFNT but not oxytocin. BEE cells were treated for 3 h with vehicle control, oxytocin, 
BEL, PYR-1, MAFP or IFNT. The symbols, + and -, indicate the presence or absence of treatments, respectively. PLA2G4C 
activity assays were performed on cellular lysates as described in the Methods. Inhibition of activity by MAFP but not PYR-1 or 
BEL demonstrates that PLA2G4C activity was measured. Columns with different superscripts are significantly different (p < 
0.05).
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